(Press-News.org) DURHAM, N.C. – A collaborative effort between Duke Medicine researchers and neurosurgeons and scientists in China has produced new genetic insights into a rare and deadly form of childhood and young adult brain cancer called brainstem glioma.
The researchers identified a genetic mutation in the tumor cells that plays a role in both the growth and the death of a cell. Additionally, the mutation to the newly identified gene may also contribute to the tumor's resistance to radiation.
The findings, published online in the journal Nature Genetics on June 1, 2014, provide both immediate and long-term benefits. Knowing that this mutation may render radiation ineffective, patients could be spared that therapy. The mutation would also serve as a strong candidate for drug development.
The researchers conducted genetic tests and found that many of the tumor cells had a mutation in a gene called PPM1D, which causes cells to proliferate and avoid natural death. It is the first time this mutation has been found to be a major driving force in the development of brainstem gliomas; it is not evident in other brain tumors.
If tumors have this PPM1D mutation, they do not have another more common genetic mutation to the TP53 gene, a tumor suppressor that, when defective, is linked to half of all cancers.
"This finding has immediate clinical applications, because either mutation - PPM1D or TP53 – cause the tumor cells to be resistant to radiation," said senior author Hai Yan, M.D., Ph.D., a professor of pathology at Duke University School of Medicine. "Knowing that could spare patients from an ineffective treatment approach."
Additionally, the PPM1D genetic mutation is a strong candidate for new drug development.
"This finding gives us a clue as to why these particular tumors are growing inappropriately," said co-author Zachary Reitman, M.D., Ph.D., a research associate at Duke. "These clues may help us to design better treatments for this type of cancer."
Yan said his lab is working to identify new treatments that could target the PPM1D genetic mutation and shut down its cancer-growing capabilities.
"PPM1D is itself a target for drug development, because the gene mutation causes cells to avoid death and proliferate," Yan said. "In drug development, it's easier to turn that growth function off than it is to switch on the cell's defective tumor suppression mechanism."
INFORMATION:
In addition to Yan, Reitman and Zhang, study authors include Lee H. Chen; Hong Wan; Rui Yang; Zhaohui Wang; Jie Feng, Shaohua Yang; Sian Jones; Sizhen Wang; Weixin Zhou; Huishan Zhu; Patrick J. Killela; Junting Zhang; Zhen Wu; Guilin Li; Shuyu Hao; Yu Wang; Joseph B. Webb; Henry S. Friedman; Allan H. Friedman; Roger E. McLendon; Yiping He; and Darell D. Bigner.
This study was partly supported by grants from the National Cancer Institute (R01CA140316); the American Cancer Society; the Pediatric Brain Tumor Foundation Institute; Voices Against Brain Cancer Foundation; James S. McDonnell Foundation; the V Foundation; Accelerate Brain Cancer Cure Foundation; and the Natural Science Foundation of China.
Newly identified brain cancer mutation will aid drug development
2014-06-01
ELSE PRESS RELEASES FROM THIS DATE:
Lasers create table-top supernova
2014-06-01
Laser beams 60,000 billion times more powerful than a laser pointer have been used to recreate scaled supernova explosions in the laboratory as a way of investigating one of the most energetic events in the Universe.
Supernova explosions, triggered when the fuel within a star reignites or its core collapses, launch a detonation shock wave that sweeps through a few light years of space from the exploding star in just a few hundred years. But not all such explosions are alike and some, such as Cassiopeia A, show puzzling irregular shapes made of knots and twists.
To investigate ...
Smokers with gene defect have 1 in 4 chance of developing lung cancer
2014-06-01
Around a quarter of smokers who carry a defect in the BRCA2 gene will develop lung cancer at some point in their lifetime, a large-scale, international study reveals.
Scientists announce a previously unknown link between lung cancer and a particular BRCA2 defect, occurring in around 2 per cent of the population, in research published in Nature Genetics today (Sunday).
The defect in BRCA2 - best known for its role in breast cancer - increases the risk of developing lung cancer by about 1.8 times.
Smokers as a group have a high lifetime risk of around 13 per cent (16 ...
Shining a light on memory
2014-06-01
Using a flash of light, scientists have inactivated and then reactivated a memory in genetically engineered rats. The study, supported by the National Institutes of Health, is the first cause-and-effect evidence that strengthened connections between neurons are the stuff of memory.
"Our results add to mounting evidence that the brain represents a memory by forming assemblies of neurons with strengthened connections, or synapses, explained Roberto Malinow, M.D., Ph.D., of the University of California, San Diego (UCSD), a grantee of the NIH's National Institute of Mental ...
Study identifies new genetic cause of male reproductive birth defects
2014-06-01
HOUSTON – (June 1, 2014) – Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.
"Cryptorchidism and hypospadias are among the most common birth defects but the causes are usually unknown," said Dr. Dolores Lamb, director of the Center for Reproductive Medicine at Baylor, professor and vice chair for research of urology and molecular and cellular biology at Baylor and lead author of the report.
Cryptorchidism is ...
'Quadrapeutics' works in preclinical study of hard-to-treat tumors
2014-06-01
HOUSTON -- (June 1, 2014) -- The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells -- often by blowing them apart -- without harming surrounding normal organs. The research, which is available online this week Nature Medicine, reports that Rice's "quadrapeutics" technology was 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant head and neck tumors.
The work was conducted by ...
CSIC develops a software able to identify and track an specific individual within a group
2014-06-01
Researchers from the Spanish National Research Council (CSIC) have developed a software based on the discovery of some algorithms that enable the identification of each individual, therefore allowing their tracking within the group. Thus, the door opens to the quantitative study of the rules of social interaction for many species. The work has been published in the Nature Methods journal.
Animals that move in groups make decisions considering what other members of their community do. To find out the rules of these interactions, researchers record monitoring videos through ...
Graphene's multi-colored butterflies
2014-06-01
Writing in Nature Physics, a large international team led by Dr Artem Mishchenko and Sir Andre Geim from The University of Manchester shows that the electronic properties of graphene change dramatically if graphene is placed on top of boron nitride, also known as 'white graphite'.
One of the major challenges for using graphene in electronics applications is the absence of a band gap, which basically means that graphene's electrical conductivity cannot be switched off completely. Whatever researchers tried to do with the material so far, it remained highly electrically ...
Paired enzyme action in yeast reveals backup system for DNA repair
2014-06-01
The combined action of two enzymes, Srs2 and Exo1, prevents and repairs common genetic mutations in growing yeast cells, according to a new study led by scientists at NYU Langone Medical Center.
Because such mechanisms are generally conserved throughout evolution, at least in part, researchers say the findings suggest that a similar DNA repair kit may exist in humans and could serve as a target for controlling some cancers and treating a rare, enzyme-linked genetic disorder called Aicardi-Goutieres syndrome. The syndrome, an often fatal neurological condition, is found ...
Pitt team first to detect exciton in metal
2014-06-01
PITTSBURGH—University of Pittsburgh researchers have become the first to detect a fundamental particle of light-matter interaction in metals, the exciton. The team will publish its work online June 1 in Nature Physics.
Mankind has used reflection of light from a metal mirror on a daily basis for millennia, but the quantum mechanical magic behind this familiar phenomenon is only now being uncovered.
Physicists describe physical phenomena in terms of interactions between fields and particles, says lead author Hrvoje Petek, Pitt's Richard King Mellon Professor in the Department ...
Subtle change in DNA, protein levels determines blond or brunette tresses, study finds
2014-06-01
STANFORD, Calif. — A molecule critical to stem cell function plays a major role in determining human hair color, according to a study from the Stanford University School of Medicine.
The study describes for the first time the molecular basis for one of our most noticeable traits. It also outlines how tiny DNA changes can reverberate through our genome in ways that may affect evolution, migration and even human history.
"We've been trying to track down the genetic and molecular basis of naturally occurring traits — such as hair and skin pigmentation — in fish and humans ...